Epothilones: From Discovery to Clinical Trials

Author(s): Stefano Forli

Journal Name: Current Topics in Medicinal Chemistry

Volume 14 , Issue 20 , 2014

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Epothilones are natural compounds isolated from a myxobacterium at the beginning of the 1990s, and showed a remarkable anti-neoplastic activity. They act through the same mechanism of action of paclitaxel, by stabilizing microtubules and inducing apoptosis. Although, their chemical structure, simpler than taxanes, makes them more suitable for derivatization. Their interesting pharmacokinetic and bioavailabilty profiles, and the activity against paclitaxel-resistant cell lines make them interesting therapeutic agents. Here a brief historical perspective of epothilones is presented, since their isolation, the identification of their mechanism of action and activity, to the recent clinical trials.

Keywords: Cancer, Drug design, MDR, Microtubules MSAA, Pharmacophore, SAR, Tubulin.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 12 December, 2014
Page: [2312 - 2321]
Pages: 10
DOI: 10.2174/1568026614666141130095855
Price: $65

Article Metrics

PDF: 44